Clinical Trial Update: Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison [Phase 3]

View source ↗

Summary

Phase 3 trial directly compared Rubidium-82 PET with Tc-99m-MIBI SPECT imaging in coronary artery disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rubidium-82 (rubidium-82)
• Tc-99m MIBI (technetium-99m sestamibi)

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED